[A new quality of the therapy of anxiety and depression--escitalopram].
Neznanov
N G
NG
Bortsov
A V
AV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D001007:Anxiety / Q000175:diagnosis / Q000188:drug therapy*; D015283:Citalopram / Q000008:administration & dosage / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D004195:Disease Models, Animal; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016584:Panic Disorder / Q000175:diagnosis / Q000188:drug therapy; D010919:Placebos; D011320:Primary Health Care; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D013237:Stereoisomerism
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors